Iambic Therapeutics CEO Tom Miller (L) and new CFO Michael Secora
January 6, 2025 06:30 AM EST
People
Startups
AI

Ex­clu­sive: AI biotech Iambic snags CFO who helped steer Re­cur­sion-Ex­sci­en­tia deal

Kyle LaHucik

Senior Reporter

Iambic Ther­a­peu­tics has hired a CFO, poach­ing an ex­ec­u­tive who helped en­gi­neer the first big merg­er in the AI-dri­ven biotech field last …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

Will CRISPR mat­ter?

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times